New York Life Investment Management’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
New York Life Investment Management's MRK Position: Q2 2026 in Review
New York Life Investment Management reduced its Merck (MRK) stake by 0.23% in Q2 2026, selling an estimated $92.5K and leaving 343,960 shares worth $44.2M. The position accounts for 0.31% of the portfolio, ranked #64.
New York Life Investment Management first reported a position in MRK in Q4 2013 and has held it in 21 quarters since. The position peaked at $51.2M in Q1 2024. 2,682 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- New York Life Investment Management held 343,960 shares of Merck worth $44.2M as of Q2 2026.
- New York Life Investment Management sold 790 Merck shares in Q2 2026, an estimated $92.5K.
- Merck made up 0.31% of New York Life Investment Management's portfolio in Q2 2026, its #64 holding.
- New York Life Investment Management first reported a position in Merck in Q4 2013 and has held it in 21 quarters since.
- New York Life Investment Management's Merck position peaked at $51.2M in Q1 2024.
- 2,682 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on New York Life Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.